Live Breaking News & Updates on Gossamer Bio Inc|Page 1

Stay updated with breaking news from Gossamer bio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary. ....

Gossamer Bio Inc , Compensation Committee Of Gossamer Board Directors , Gossamer Bio , Compensation Committee , Inducement Incentive Award Plan , Nasdaq Listing Rule , Nasdaq Global Select Market ,

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO (BUSINESS WIRE) Jun 7, 2024 ....

United States , Bryan Giraudo , Gossamer Bio Inc , Compensation Committee Of Gossamer Board Directors , Compensation Committee , Gossamer Bio , Inducement Incentive Award Plan , Nasdaq Listing Rule , Nasdaq Global Select Market , For Investors , Chief Operating Officer , Chief Financial , Business Wire ,

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

07.06.2024 - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with . ....

Lang Schwarz , Gossamer Bio Inc , Compensation Committee Of Gossamer Board Directors , Gossamer Bio , Compensation Committee , Inducement Incentive Award Plan , Nasdaq Listing Rule , Nasdaq Global Select Market , Gossamer Bio Stock ,

Monashee Investment Management LLC Reduces Stake in Gossamer Bio, Inc. (NASDAQ:GOSS)

Monashee Investment Management LLC lessened its stake in Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) by 34.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,459,854 shares of the company’s stock after selling 1,844,358 shares during the period. Gossamer Bio […] ....

United States , Faheem Hasnain , Piper Sandler , Goldman Sachs Group , Exchange Commission , York Mellon Corp , Gossamer Bio Inc , Monashee Investment Management , Citigroup Inc , Gossamer Bio , Free Report , Investment Management , New York Mellon Corp , Advocates Investment Management , Capital Management , Monaco Asset Management , Bio Stock Down , Get Free Report , Gossamer Bio Daily ,

Gossamer, Chiesi Ink $486M Collab Deal - San Diego Business Journal

Gossamer, Chiesi Ink $486M Collab Deal - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Giuseppe Accogli , Chiesi Farmaceutici , Faheem Hasnain , Gossamer Bio Inc , Gossamer Bio ,